The effect of liraglutide on endothelial function in patients with type 2 diabetes
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The effect of liraglutide on endothelial function in patients with type 2 diabetes
Authors
Keywords
-
Journal
Diabetes & Vascular Disease Research
Volume 11, Issue 6, Pages 419-430
Publisher
SAGE Publications
Online
2014-09-12
DOI
10.1177/1479164114547358
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cardiovascular Actions of Incretin-Based Therapies
- (2014) John R. Ussher et al. CIRCULATION RESEARCH
- Albiglutide: First Global Approval
- (2014) Raewyn M. Poole et al. DRUGS
- Alogliptin ameliorates postprandial lipemia and postprandial endothelial dysfunction in non- diabetic subjects: a preliminary report
- (2013) Yoko Noda et al. Cardiovascular Diabetology
- Liraglutide suppresses postprandial triglyceride and apolipoprotein B48 elevations after a fat-rich meal in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, cross-over trial
- (2013) K. Hermansen et al. DIABETES OBESITY & METABOLISM
- Effects of 6 months glucagon-like peptide-1 receptor agonist treatment on endothelial function in type 2 diabetes mellitus patients
- (2013) N. D. Hopkins et al. DIABETES OBESITY & METABOLISM
- Lixisenatide: First Global Approval
- (2013) Shelley Elkinson et al. DRUGS
- GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure
- (2013) Minsuk Kim et al. NATURE MEDICINE
- Dipeptidyl Peptidase‐4 Inhibitors Attenuate Endothelial Function as Evaluated by Flow‐Mediated Vasodilatation in Type 2 Diabetic Patients
- (2013) Makoto Ayaori et al. Journal of the American Heart Association
- Effects of Exenatide vs. Metformin on endothelial function in obese patients with pre-diabetes: a randomized trial
- (2012) Aaron S Kelly et al. Cardiovascular Diabetology
- Glucagon-Like Peptide 1 Recruits Microvasculature and Increases Glucose Use in Muscle via a Nitric Oxide-Dependent Mechanism
- (2012) W. Chai et al. DIABETES
- Exenatide improves endothelial function assessed by flow mediated dilation technique in subjects with type 2 diabetes: Results from an observational research
- (2012) Concetta Irace et al. Diabetes & Vascular Disease Research
- Addition of liraglutide in patients with Type 2 diabetes well controlled on metformin monotherapy improves several markers of vascular function
- (2012) T. Forst et al. DIABETIC MEDICINE
- A comparison of currently available GLP-1 receptor agonists for the treatment of type 2 diabetes
- (2012) Eduard Montanya EXPERT OPINION ON PHARMACOTHERAPY
- The Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Improves Vascular Endothelial Function in Type 2 Diabetes
- (2012) Yoshiaki Kubota et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Targeting the glucagon receptor family for diabetes and obesity therapy
- (2012) Young Min Cho et al. PHARMACOLOGY & THERAPEUTICS
- Brain GLP-1 Signaling Regulates Femoral Artery Blood Flow and Insulin Sensitivity Through Hypothalamic PKC-
- (2011) C. Cabou et al. DIABETES
- A GLP-1 receptor agonist liraglutide inhibits endothelial cell dysfunction and vascular adhesion molecule expression in an ApoE-/- mouse model
- (2011) Tracey Gaspari et al. Diabetes & Vascular Disease Research
- Vildagliptin Improves Endothelium-Dependent Vasodilatation in Type 2 Diabetes
- (2011) P. C. M. van Poppel et al. DIABETES CARE
- Flow-Mediated Dilation and Cardiovascular Event Prediction
- (2011) Daniel J. Green et al. HYPERTENSION
- Inhibition of Monocyte Adhesion to Endothelial Cells and Attenuation of Atherosclerotic Lesion by a Glucagon-like Peptide-1 Receptor Agonist, Exendin-4
- (2010) M. Arakawa et al. DIABETES
- Improvement of Postprandial Endothelial Function After a Single Dose of Exenatide in Individuals With Impaired Glucose Tolerance and Recent-Onset Type 2 Diabetes
- (2010) J. Koska et al. DIABETES CARE
- RETRACTED ARTICLE: A glucagon-like peptide-1 (GLP-1) analogue, liraglutide, upregulates nitric oxide production and exerts anti-inflammatory action in endothelial cells
- (2010) Y. Hattori et al. DIABETOLOGIA
- Glucagon-Like Peptide (GLP)-1(9-36)Amide-Mediated Cytoprotection Is Blocked by Exendin(9-39) Yet Does Not Require the Known GLP-1 Receptor
- (2010) Kiwon Ban et al. ENDOCRINOLOGY
- A long-acting glucagon-like peptide-1 analogue attenuates induction of plasminogen activator inhibitor type-1 and vascular adhesion molecules
- (2009) Hongbin Liu et al. JOURNAL OF ENDOCRINOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started